Loading...

Pacific Blue™ anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Blue_091207
C57BL/6 mouse splenocytes stained with Pacific Blue™ 30-F11
  • 30-F11_Blue_091207
    C57BL/6 mouse splenocytes stained with Pacific Blue™ 30-F11
Compare all formats See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
103125 25 µg $94
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103126 100 µg $215
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD45 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  2. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  3. Quintero H, et al. 2022. Cell Rep. 40:111324. PubMed
  4. Berube A, et al. 2022. Viruses. 14:. PubMed
  5. Perveen S, et al. 2012. PLoS One. 7:e51945. PubMed
  6. Zabala M, et al. 2020. Cell Stem Cell. 27(2):284-299.e8. PubMed
  7. Barkaway A, et al. 2021. Immunity. . PubMed
  8. Girbl T et al. 2018. Immunity. 49(6):1062-1076 . PubMed
  9. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  10. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  11. Ma L, et al. 2009. J Immunol. 183:1044. PubMed
  12. Li H, et al. 2022. Cell Rep Med. 3:100554. PubMed
  13. Reinitz F, et al. 2022. Elife. 11:. PubMed
  14. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  15. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  16. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  17. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  18. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  19. Skowron K, et al. 2016. Sci Rep. 6:35854. PubMed
  20. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  21. Wietecha MS, et al. 2020. Nat Commun. 2.266666667. PubMed
  22. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  23. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  24. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  25. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  26. Fitzgerald B, et al. 2021. Cell Rep Methods. 1:. PubMed
  27. Súarez-López L, et al. 2021. iScience. 24:103406. PubMed
  28. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  29. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  30. Fernandes RA, et al. 2020. eLife. 9:e58463.. PubMed
  31. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  32. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  33. Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed
  34. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  35. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  36. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  37. Peuhu E, et al. 2017. PLoS One. 12:e0186628. PubMed
  38. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  39. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  40. Chan A, et al. 2014. Am J Pathol. 184:1411. PubMed
  41. Scheele C, et al. 2017. Nature. 542:313-317. PubMed
  42. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  43. Minatoguchi S, et al. 2022. Sci Rep. 12:5389. PubMed
  44. Karaman S, et al. 2022. J Exp Med. 219:. PubMed
  45. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  46. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  47. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  48. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  49. Nie M, et al. 2016. Cell Death Dis. 7:e2261. PubMed
  50. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  51. Lee C, et al. 2014. Cancer Res. 74:341. PubMed
  52. Shi C, et al. 2010. J Immunol. 184:6266. PubMed
  53. An J, et al. 2022. iScience. 25:103570. PubMed
  54. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  55. Menzel L, et al. 2022. STAR Protoc. 3:101267. PubMed
  56. Wan W, et al. 2013. Cardiovasc Res. 97:580. PubMed
  57. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  58. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  59. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  60. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  61. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  62. Lovisa S, et al. 2020. Sci Signal. 13:00. PubMed
  63. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  64. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  65. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  66. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  67. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  68. Hartwig T et al. 2018. Cell reports. 25(13):3564-3572 . PubMed
  69. Bignami F, et al. 2017. Acta Ophthalmol. 95:e641. PubMed
  70. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  71. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  72. Cheah M, et al. 2015. Proc Natl Acad Sci U S A. 112:4725. PubMed
  73. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  74. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  75. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  76. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  77. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  78. Mender I, et al. 2020. Cancer Cell. 38(3):400-411.e6. PubMed
  79. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  80. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  81. Frasca D, et al. 2020. Front Immunol. 11:328. PubMed
  82. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  83. Cai S et al. 2017. Cell stem cell. 20(2):247-260 . PubMed
  84. Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed
  85. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  86. Gusarova GA, et al. 2021. JCI Insight. 6: . PubMed
  87. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  88. Chang J, et al. 2016. J Am Soc Nephrol. 10.1681/ASN.2015121356. PubMed
  89. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  90. Diéguez–Hurtado R, et al. 2019. Nat Commun. 10:2817. PubMed
  91. Lee S et al. 2017. Cell host & microbe. 22(4):449-459 . PubMed
  92. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  93. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  94. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  95. Sungur C, et al. 2013. Proc Natl Acad Sci U S A. 110:7401. PubMed
  96. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  97. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  98. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  99. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  100. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  101. Spix B, et al. 2022. Nat Commun. 13:318. PubMed
  102. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  103. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  104. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  105. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  106. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  107. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  108. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  109. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  110. Nishida C, et al. 2012. Blood. 119:5405. PubMed
  111. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  112. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  113. McAndrews KM, et al. 2021. J Biol Chem. 296:100523. PubMed
  114. Huang S, et al. 2020. Cell. 184(2):441-459.e25. PubMed
  115. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  116. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  117. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  118. Chia JSJ, et al. 2018. Nutrients. 1.313194444. PubMed
  119. Li Y et al. 2018. Cell Stem Cell. 23(2):181-192 . PubMed
  120. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  121. Engblom C, et al. 2017. Science. 358:6367. PubMed
  122. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  123. Choudhary S, et al. 2012. J Virol. 86:114. PubMed
  124. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  125. Kato K, et al. 2018. Nat Commun. 48:120. PubMed
  126. Li C, et al. 2018. Cell. 174:285. PubMed
  127. Iwata TN, et al. 2018. Mol Cancer Ther. 17:1494. PubMed
  128. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  129. Ualiyeva S, et al. 2021. Bio Protoc. 11:e4163. PubMed
  130. Ko FC, et al. 2021. J Bone Miner Res. 36:1510. PubMed
  131. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  132. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  133. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  134. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  135. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  136. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  137. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  138. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  139. Tang S, et al. 2022. Virol J. 19:32. PubMed
  140. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  141. Yao Z, et al. 2020. Cancer Res. 80:1171. PubMed
  142. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  143. Gomes AM, et al. 2018. Cell Rep. 25:2821. PubMed
  144. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  145. Weidner T, et al. 2021. Nat Protoc. 16:3210. PubMed
  146. Yamaguchi T, et al. 2020. Eur J Immunol. 50:110. PubMed
  147. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  148. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  149. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  150. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  151. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  152. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  153. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  154. Chen Y, et al. 2021. Cancer Cell. 39(4):548-565.e6. PubMed
  155. Carson W, et al. 2011. PLoS One. 6:e20385. PubMed
  156. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  157. Forese MG et al. 2019. Glia. 68(1):95-110 . PubMed
  158. Zilionis R et al. 2019. Immunity. 50(5):1317-1334 . PubMed
  159. Tucey TM et al. 2018. Cell metabolism. 27(5):988-1006 . PubMed
  160. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  161. Shue YT, et al. 2022. Nat Commun. 13:2690. PubMed
  162. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  163. Pattabiraman D, et al. 2016. Science. 351: aad3680. PubMed
  164. Borrelli MR, et al. 2020. Stem Cells Transl Med. 1.347916667. PubMed
  165. Hemanthakumar KA, et al. 2021. eLife. 10:00. PubMed
  166. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  167. Eilken H, et al. 2017. Nat Commun. . 10.1038/s41467-017-01738-3. PubMed
  168. Thurlow LR, et al. 2018. Cell Host Microbe. 24:261. PubMed
  169. Avey D et al. 2018. Cell reports. 24(13):3619-3629 . PubMed
  170. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  171. Mahmoudi S, et al. 2019. Nature. 574:553. PubMed
  172. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  173. Shao S, et al. 2020. Proc Natl Acad Sci U S A. 117:8845. PubMed
  174. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
  175. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  176. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  177. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  178. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  179. Jiang Q, et al. 2008. Blood. 112:2858. PubMed
  180. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  181. Barry DM, et al. 2019. Nat Commun. 4.378472222. PubMed
  182. Jorge Domínguez‐Andrés et al. 2017. Immunity. 46(6):1059-1072 . PubMed
  183. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  184. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
RRID
AB_493536 (BioLegend Cat. No. 103125)
AB_493535 (BioLegend Cat. No. 103126)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account